Exploratory Study of Norepinephrine to Prevent Alopecia in Head and Neck Cancer Patients Treated With Radiotherapy
Status:
Terminated
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
The study will evaluate the safety of topical norepinephrine in head and neck cancer patients
who are receiving treatment with intensity modulated radiotherapy (IMRT).
The study will also provide information about whether topical norepinephrine can prevent or
decrease the severity of the radiation-induced alopecia experienced by these patients.
Phase:
Phase 1
Details
Lead Sponsor:
ProCertus BioPharm, Inc
Collaborator:
H. Lee Moffitt Cancer Center and Research Institute